//
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients
Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y
The year in cardiology: heart failure: The year in cardiology 2019